Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Newborn Heart Rate as a Catalyst for Improved Survival (NeoBeat Study)

NCT03799861 is registered in ClinicalTrials.gov with American Academy of Pediatrics as lead sponsor.

NCT NCT03799861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03799861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Newborn Heart Rate as a Catalyst for Improved Survival (NeoBeat Study)
Lead sponsor
American Academy of Pediatrics
Phase
Observational
Overall status
Completed
Start date
July 5, 2018
Completion date
October 31, 2020
Enrollment
24,034 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal bradycardia, neonatal respiratory depression, neonatal resuscitation, stillbirth